Medical translation services for pharmaceutical and medical device companies

In medicine, pharmaceuticals and medical technology, words are not just a matter of style. They help explain how a product should be used, what risks need to be understood and which information must be available to patients, healthcare professionals, regulators and business partners.

That is why medical translation services require more than linguistic accuracy. They call for sector knowledge, terminology control and a clear understanding of how regulated content is used across different markets.

‍

Why medical and pharmaceutical texts need specialist translation

Medical and pharmaceutical content often deals with information that directly affects safety, compliance and trust. A poorly translated instruction, label, dosage reference or technical term can create confusion, delay approval processes or expose companies to unnecessary risk.

Specialist translation is especially important for content such as:

• Instructions for use
• Product labels and packaging
• Technical documentation
• Clinical and regulatory documentation
• Patient information leaflets
• Training materials for healthcare professionals
• Marketing and website content for international markets.

The challenge is not only to translate the words. It is to preserve the meaning, apply the correct terminology and adapt the content to the expectations of each target audience.

‍

MDR, IVDR and the growing role of language

The European regulatory framework for medical devices has become more demanding in recent years. The Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR) changed the way many products are assessed, documented and placed on the EU market.

These regulations affect medical device manufacturers, including companies working with software, diagnostics, connected devices and in vitro diagnostic devices . They also increase the importance of clear, consistent and well-managed multilingual documentation.

For manufacturers, this means that language should not be treated as a final production step. Translation and localisation need to be considered early, especially when preparing documentation for different EU markets, notified bodies, healthcare professionals and end users.

For a broader overview of the regulatory framework, the EU medical device legislation provides useful context on MDR, IVDR and the responsibilities connected with certain categories of medical devices.

‍

Where localisation adds value

Medical localisation goes further than direct translation. It adapts content so that it works naturally and accurately in a specific market, language and regulatory environment.

This can involve adapting:

• Terminology used by healthcare professionals
• Country-specific labelling conventions
• Measurement units, formatting and document structure
• Tone and readability for patient-facing content
• Product claims and supporting information
• Digital health content, apps and software interfaces.

In fast-moving sectors such as medical technology and diagnostics, this matters even more. Organisations such as MedTech Europe highlight how innovative and diverse the European medical technology sector is, with products ranging from simple medical supplies to complex diagnostic tools and connected technologies.

As products become more digital, connected and data-driven, multilingual content also becomes more complex. User interfaces, help content, software strings, technical documentation and regulatory files all need to work together.

‍

Consistency is part of quality

In regulated sectors, consistency is not just a nice-to-have. It supports clarity, reduces ambiguity and helps teams manage large volumes of multilingual content more efficiently.

This is where terminology management becomes especially useful. Approved terminology helps ensure that the same concept is translated consistently across technical files, labels, IFUs, marketing assets and digital platforms.

A strong language process may include:

• Validated glossaries
• Translation memories
• Quality checks
• Subject-matter review
• Clear workflows between internal teams, translators and reviewers.

For pharmaceutical and medical device companies, this helps protect both brand consistency and regulatory accuracy.

‍

Human expertise, supported by the right processes

Automation and language technology can support medical and pharmaceutical translation, especially when companies manage large volumes of recurring content. However, these tools need to be used carefully.

In sensitive and regulated content, human expertise remains central. Translators need to understand the subject matter, the target audience and the risks of ambiguity. Reviewers need to check not only grammar, but also terminology, meaning and usability.

At t’works, life sciences translation combines linguistic expertise with structured processes, helping companies manage multilingual content with greater confidence. Talk to us about your next project. 

‍

Clear language helps products travel safely

For medical, pharmaceutical and medtech companies, international growth depends on more than product innovation. It also depends on whether the right information is understood clearly in every market where the product is used.

Professional localisation services help make that possible. They support accuracy, consistency and readability across languages, while helping companies communicate with regulators, healthcare professionals, partners and patients in a way that feels clear and reliable.

‍